PRFDX vs. PRHSX
PRFDX (T. Rowe Price Equity Income Fund) and PRHSX (T. Rowe Price Health Sciences Fund) are both mutual funds - PRFDX is a Large Cap Value Equities fund managed by T. Rowe Price, while PRHSX is a Health & Biotech Equities fund managed by T. Rowe Price. Over the past 10 years, PRFDX returned 11.75%/yr vs 9.98%/yr for PRHSX. A 0.66 correlation means they provide meaningful diversification when combined. PRFDX charges 0.63%/yr vs 0.80%/yr for PRHSX.
Performance
PRFDX vs. PRHSX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PRFDX achieves a 11.87% return, which is significantly higher than PRHSX's -5.20% return. Over the past 10 years, PRFDX has outperformed PRHSX with an annualized return of 11.75%, while PRHSX has yielded a comparatively lower 9.98% annualized return.
PRFDX
- 1D
- 0.44%
- 1M
- 3.91%
- YTD
- 11.87%
- 6M
- 13.88%
- 1Y
- 23.37%
- 3Y*
- 16.69%
- 5Y*
- 9.44%
- 10Y*
- 11.75%
PRHSX
- 1D
- -2.17%
- 1M
- -0.75%
- YTD
- -5.20%
- 6M
- -5.57%
- 1Y
- 17.50%
- 3Y*
- 5.15%
- 5Y*
- 2.69%
- 10Y*
- 9.98%
PRFDX vs. PRHSX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PRFDX T. Rowe Price Equity Income Fund | 11.87% | 14.60% | 11.85% | 9.75% | -3.25% | 25.60% | 1.28% | 33.66% | -9.29% | 15.46% |
PRHSX T. Rowe Price Health Sciences Fund | -5.20% | 17.75% | 1.82% | 3.03% | -12.22% | 13.50% | 30.19% | 37.88% | 1.08% | 28.04% |
Correlation
The correlation between PRFDX and PRHSX is 0.51, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.51 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.59 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.63 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.61 |
Correlation (All Time) Calculated using the full available price history since Jan 3, 1996 | 0.66 |
The correlation between PRFDX and PRHSX shifts across timeframes, from 0.51 (1 year) to 0.66 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PRFDX vs. PRHSX — Risk / Return Rank
PRFDX
PRHSX
PRFDX vs. PRHSX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Equity Income Fund (PRFDX) and T. Rowe Price Health Sciences Fund (PRHSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PRFDX | PRHSX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.09 | ||
| Sortino ratioReturn per unit of downside risk | +1.50 | ||
| Omega ratioGain probability vs. loss probability | 1.41 | 1.20 | +0.21 |
| Calmar ratioReturn relative to maximum drawdown | 3.29 | 1.41 | +1.88 |
| Martin ratioReturn relative to average drawdown | 12.24 | 4.07 | +8.17 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PRFDX | PRHSX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.27 | 1.17 | +1.09 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.64 | 0.16 | +0.48 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.66 | 0.52 | +0.14 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.61 | 0.61 | -0.01 |
Drawdowns
PRFDX vs. PRHSX - Drawdown Comparison
The maximum PRFDX drawdown since its inception was -58.12%, which is greater than PRHSX's maximum drawdown of -42.96%. Use the drawdown chart below to compare losses from any high point for PRFDX and PRHSX.
Loading charts...
Drawdown Indicators
| PRFDX | PRHSX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.12% | -42.96% | -15.16% |
Max Drawdown (1Y)Largest decline over 1 year | -7.34% | -12.81% | +5.47% |
Max Drawdown (3Y)Largest decline over 3 years | -14.35% | -21.00% | +6.65% |
Max Drawdown (5Y)Largest decline over 5 years | -18.08% | -27.61% | +9.53% |
Max Drawdown (10Y)Largest decline over 10 years | -39.71% | -28.97% | -10.74% |
Current DrawdownCurrent decline from peak | -0.51% | -8.17% | +7.66% |
Average DrawdownAverage peak-to-trough decline | -6.26% | -8.75% | +2.49% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.96% | 4.44% | -2.48% |
Volatility
PRFDX vs. PRHSX - Volatility Comparison
The current volatility for T. Rowe Price Equity Income Fund (PRFDX) is 2.99%, while T. Rowe Price Health Sciences Fund (PRHSX) has a volatility of 4.89%. This indicates that PRFDX experiences smaller price fluctuations and is considered to be less risky than PRHSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PRFDX | PRHSX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 2.99% | 4.89% | -1.90% |
Volatility (6M)Calculated over the trailing 6-month period | 8.01% | 11.96% | -3.95% |
Volatility (1Y)Calculated over the trailing 1-year period | 10.65% | 15.45% | -4.80% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.93% | 17.25% | -2.32% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.87% | 19.26% | -1.39% |
PRFDX vs. PRHSX - Expense Ratio Comparison
PRFDX has a 0.63% expense ratio, which is lower than PRHSX's 0.80% expense ratio.
Dividends
PRFDX vs. PRHSX - Dividend Comparison
PRFDX's dividend yield for the trailing twelve months is around 2.44%, less than PRHSX's 12.76% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRFDX T. Rowe Price Equity Income Fund | 2.44% | 2.76% | 8.91% | 6.19% | 6.61% | 8.78% | 3.55% | 12.53% | 11.43% | 8.97% | 7.75% | 7.48% |
PRHSX T. Rowe Price Health Sciences Fund | 12.76% | 12.09% | 12.89% | 5.21% | 1.77% | 7.46% | 7.16% | 12.29% | 6.57% | 7.43% | 4.55% | 11.34% |
Frequently Asked Questions
PRFDX and PRHSX have a correlation of 0.51, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PRHSX has higher volatility (4.89%) compared to PRFDX (2.99%). In terms of maximum drawdown, PRFDX dropped -58.12% vs PRHSX's -42.96%.
PRFDX currently has the higher Sharpe Ratio (2.27 vs 1.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PRFDX and PRHSX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer